GENZ Forum Topics
- All Comments on GENZ
- General Discussion on GENZ
- Banks Hit Bottom – Cramer’s Mad Money (7/21/08) [view article]
- PTC and Genzyme in $437M Gene Therapy Deal [view article]
- Big Biotech Booms But IBB Falls Flat [view article]
- Biotech is Healthy - Fast Money Recap (7/8/08) [view article]
- FDA Stings Pharma, Big and Small [view article]
- 10 Biotechs in Stem Cells that Could Profit Under the Democrats [view article]
- Isis Pharmaceuticals Panic Overdone [view article]
- Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF? [view article]
- Genzyme To Build $90 Million R&D Center in Beijing [view article]
- Pfizer Should Buy Amgen or Wyeth - Credit Suisse [view article]
- A Long List of Possible Shorts [view article]
Recent GENZ Articles
- PTC and Genzyme in $437M Gene Therapy Deal
- Big Biotech Booms But IBB Falls Flat
- In Tech We Trust - Fast Money Recap (6/20/08)
- FDA Stings Pharma, Big and Small
- Biotech Fundamentals Still Look Strong
- 10 Biotechs in Stem Cells that Could Profit Under the Democrats
- Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
- Biotech in Review: Investments in China Drug Development
- Isis Pharmaceuticals Panic Overdone
- Genzyme To Build $90 Million R&D Center in Beijing
- Full List of Articles »
loading ...
Banks Hit Bottom – Cramer’s Mad Money (7/21/08) [view article]
ShortingHurt - Long, hard read but holy shit - I'm going to start sleeping with one eye open and my Glock under my pillow.Part way through I'm thinking this sounds like a lucrative venture for the "mob". Guess I wasn't the first one it occurred to.
If you wrote a movie about this nobody would believe it - this is wilder than fiction. The worst part is it would seem to be so damn obvious to any one in the SEC or any area of the business.
Used car dealers, lawyers and real estate people just moved up a couple of notches on my slime ball list. Reply
Banks Hit Bottom – Cramer’s Mad Money (7/21/08) [view article]
Cramer may have listened to this:media.lewrockwell.com/...
Reply
e
Banks Hit Bottom – Cramer’s Mad Money (7/21/08) [view article]
Oh yeah UBS is all over their 52 week high. Replynger
Banks Hit Bottom – Cramer’s Mad Money (7/21/08) [view article]
I'm sure Cramer's smart, but it seems he often jumps on the bandwagon & touts stocks when they're at 52 week highs, which is about the time you might want to think about getting out of them. ReplyBanks Hit Bottom – Cramer’s Mad Money (7/21/08) [view article]
Amazing, he's calling a bottom in financials during what will be the worst financial crisis in our history. So we are goign to erase decades of greed, mismanagement and fraud with only a couple of financial institutions failing. We will be at a bottom when thousands, THOUSANDS of banks have failed, no one wants to buy stocks, PE in mid single digits, only a few posts on SA and Cramer's show is off the air because ratings are so low. He's the stock market version of Flip This House CNBC should rename his show Flip this Stock Replyg
Banks Hit Bottom – Cramer’s Mad Money (7/21/08) [view article]
Isn't this the same Jim Cramer who told us about "toxic rivers of debt" and to sell JPM, USB, WFC and BAC just a few weeks ago? I suspect he may just be a "pump and dump". Anyway, I have a laugh looking over his past videos. He MUST be working in collusion with some hedge fund. I cannot believe anything this idiot says.Read this please. It's worth your time, I promise.
www.deepcapture.com/
Then if you want to see more, have a look at this:
www.deepcapturethemovi...
And another site about the subject:
megamata.com/forum/vie...
Then sign this...
www.petitiononline.com... Reply
Banks Hit Bottom – Cramer’s Mad Money (7/21/08) [view article]
Banner Bank is in the Seattle high tech and aerospace area and seems to have zero subpar loan exposure. Strong economic area and this Bank has been unfairly taken down...look for a great quarterly report coming up is my analysis based on my own research. Check it out BANR...when you check out all the other recommendations. ReplyPTC and Genzyme in $437M Gene Therapy Deal [view article]
Nice to see companies working on targets that "not everybody else" is working on (like kinases...). ReplyBig Biotech Booms But IBB Falls Flat [view article]
IBB is up over .80 today, you call that flat??? ReplyBiotech is Healthy - Fast Money Recap (7/8/08) [view article]
Cramer like Providence Energy Trust...one of the partner of Founder Energy that got bought out by PVX is Gary Schellenberg, now CEO of TNR Gold
Thing will FLY soon.
TNR.v on TSX up 30% since last month Reply
FDA Stings Pharma, Big and Small [view article]
The FDA is broken. If you ask the "man on the street", he might say the FDA approves "dangerous" drugs because they are not 100% safe in humans at "elephant" dosages. But, the truth is, the FDA's snail pace is costing the drug industry billions and adversely impacting consumer health. A perfectly safe used-in-the-EU testosterone product from Invedus was put on lengthy delay because a patient coughed a few times in clinical trials. "Plan B" OTC was delayed for years because the "Bushies" have a purely political distaste for women's health products.The FDA is run right now with all the competence of FEMA during Katrina-- it's all do-nothing cronies. Reply
FDA Stings Pharma, Big and Small [view article]
the FDA has been awful for a very long time.Dub Ya is not the one to blame here so get past it.
leaks from the lab > get past it.
these stocks are lousy because of their growth potential and the fear of further profit restrictions. Reply
FDA Stings Pharma, Big and Small [view article]
But the king george iii bush administration has been so honest with his peasants ......... most corrupt and worst EVER ReplyFDA Stings Pharma, Big and Small [view article]
Article by Evelyn Pringle ON FDA CORRUPTION & SELLING OF INSIDER INFORMATIONwww.opednews.com/artic...
Bush's FDA - Perpetual Leaker of Insider Information
by Evelyn Pringle Page 1 of 7 page(s)
Bush's FDA - Perpetual Leaker of Insider Information
The steady leaking of insider information about products under review by the FDA has caused enormous losses for average American investors since the Bush Administration took control of the agency six years ago.
There are several ways that investors can profit from this type of insider information. The first is obvious, buy the stock because approval of a product will almost certainly raise a company's stock value. Investors who know about the decision ahead of time can bet the farm based on that information.
But investors who are tipped off that a product will not be approved can do the opposite. They can bet that company's stock value will fall by selling the stock short knowing full-well that the minute the news of non-approval becomes public, the stock's value will drop like a rock.
When the leaking of this type of information occurs, the losers are always the investors who play by the rules and make bets based on the best public information available. Unfortunately, in many instances, these are the very people who can least afford the loss. >>>>>&g...
Reply
e
10 Biotechs in Stem Cells that Could Profit Under the Democrats [view article]
www.investorslive.com/...CYTX - Cytori Therapeutics Inc on quite the tear lately, watch for it to test $9 before thinking about shorting if it breaks it could squeeze quick and starting jump up by a dime at a time. If it breaks it, wait for it to show weakness and break back under $9.00. Reply